Basic Information
ID: ALA646002
Type: Binding
Description: In vitro binding affinity using [3H]prazosin as radioligand against alpha-1D adrenergic receptor expressed in LTK cell
Format: BAO_0000219
Cell type: LTK
Target: Alpha-1d adrenergic receptor(ALA326)
Document: ALA1132919
In vitro binding affinity using [3H]prazosin as radioligand against alpha-1D adrenergic receptor expressed in LTK cell: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA646002
Ki
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 448.55 | 2.97 | 2.97 |
| 448.55 | 2.97 | 2.97 |
| 461.59 | 3.88 | 3.88 |
| 448.55 | 2.97 | 2.97 |
| 472.57 | 3.45 | 3.45 |
| 477.59 | 3.58 | 3.58 |
| 479.56 | 2.37 | 2.37 |
| 478.57 | 2.98 | 2.98 |
| 449.54 | 2.36 | 2.36 |
| 449.54 | 2.36 | 2.36 |
| 449.54 | 2.36 | 2.36 |
| 463.56 | 2.67 | 2.67 |
| 478.57 | 2.98 | 2.98 |
| 482.99 | 3.62 | 3.62 |
| 447.56 | 3.57 | 3.57 |
| 448.55 | 2.97 | 2.97 |
| 472.57 | 3.45 | 3.45 |
| 482.01 | 4.23 | 4.23 |
| 482.01 | 4.23 | 4.23 |
| 482.01 | 4.23 | 4.23 |
| 490.59 | 2.67 | 2.67 |
| 525.63 | 4.03 | 4.03 |
| 525.63 | 4.03 | 4.03 |
| 477.59 | 2.98 | 2.98 |
| 505.60 | 3.36 | 3.36 |
| 472.57 | 3.45 | 3.45 |
| 515.56 | 4.59 | 4.59 |
| 447.56 | 3.57 | 3.57 |
| 518.64 | 3.28 | 3.28 |
| 492.56 | 3.48 | 3.48 |
| 461.59 | 3.88 | 3.88 |
| 461.59 | 3.97 | 3.97 |
| 490.59 | 2.67 | 2.67 |
| 472.57 | 3.45 | 3.45 |
| 430.51 | 2.84 | 2.84 |
| 431.49 | 3.11 | 3.11 |
| 475.61 | 4.36 | 4.36 |
| 447.56 | 3.57 | 3.57 |
| 447.56 | 3.57 | 3.57 |
| 447.56 | 3.57 | 3.57 |